-
Creation and Characterization of Glycosyltransferase Mutants of Trypanosoma brucei
Time of Update: 2021-01-05
Here we describe a functional characterization workflow in which we create glycosyltransferase null or conditional null mutants in both the bloodstream and procyclic life-cycle forms of the parasite.
-
Research by the University of Southampton has found that the ADAMTSL1 gene variant shortens the life cycle of breast cancer patients
Time of Update: 2020-08-06
researchers say the findings "suggest that unique disease mechanisms may affect the survival of young women and provide some biological insights into why young breast cancer patients have a worse prognosis." "," Dr Tapper and his team say, the findings will provide new diagnostic and therapeutic methods for young women diagnosing early-stage breast cancer.
-
Advances in the diagnosis and treatment of glioblastoma
Time of Update: 2020-05-31
Background glioblastoma (GBM) is a common malignant brain tumor, accounting for 45% of central nervous system malignancies; The GBM prognosis is poor Nancy Ann Oberheim Bush of the Neurosurgery Group
-
Steel temperature phospation technology
Time of Update: 2020-02-25
the characteristics of phosphating film: strong adhesion with the substrate metal, strong combination, dense porous, strong adsorption to the coating Therefore, it can be used as the base of commonl
-
New breast cancer drug! Kadcyla, a Roche targeted anticancer drug, has applied in Japan for adjuvant treatment of HER2 positive early breast cancer
Time of Update: 2019-09-02
September 2, 2019 / BIOON / -- Chugai, a Japanese pharmaceutical company controlled by Roche, a Swiss pharmaceutical giant, recently announced that it had submitted an application to MHLW for approval
-
The digital transformation of pharmaceutical enterprises is imperative as big data weaves Technology Network
Time of Update: 2019-07-30
[pharmaceutical network industry trends] drug development and innovation is a long cycle, high investment and high risk process It is reported that the development of a drug usually takes 10 to 15 yea
